Axillary lymph node (ALN) status is one of the most critical prognostic factors in patients with breast cancer. However, ALN evaluation with contrast-enhanced CT (CECT) has been challenging. Machine learning (ML) is known to show excellent performance in image recognition tasks. The purpose of our study was to evaluate the performance of the ML algorithm for predicting ALN metastasis by combining preoperative CECT features of both ALN and primary tumor. This was a retrospective single-institutional study of a total of 266 patients with breast cancer who underwent preoperative chest CECT. Random forest (RF), extreme gradient boosting (XGBoost), and neural network (NN) algorithms were used. Statistical analysis and recursive feature elimination (RFE) were adopted as feature selection for ML. The best ML-based ALN prediction model for breast cancer was NN with RFE, which achieved an AUROC of 0.76 ± 0.11 and an accuracy of 0.74 ± 0.12. By comparing NN with RFE model performance with and without ALN features from CECT, NN with RFE model with ALN features showed better performance at all performance evaluations, which indicated the effect of ALN features. Through our study, we were able to demonstrate that the ML algorithm could effectively predict the final diagnosis of ALN metastases from CECT images of the primary tumor and ALN. This suggests that ML has the potential to differentiate between benign and malignant ALNs.
Background: The purpose of this study was to assess the volume of the pulmonary nodules and masses on serial chest X-rays (CXRs) from deep-learning-based automatic detection algorithm (DLAD)-based parameters. Methods: In a retrospective single-institutional study, 72 patients, who obtained serial CXRs (n = 147) for pulmonary nodules or masses with corresponding chest CT images as the reference standards, were included. A pre-trained DLAD based on a convolutional neural network was developed to detect and localize nodules using 13,710 radiographs and to calculate a localization map and the derived parameters (e.g., the area and mean probability value of pulmonary nodules) for each CXR, including serial follow-ups. For validation, reference 3D CT volumes were measured semi-automatically. Volume prediction models for pulmonary nodules were established through univariable or multivariable, and linear or non-linear regression analyses with the parameters. A polynomial regression analysis was performed as a method of a non-linear regression model. Results: Of the 147 CXRs and 208 nodules of 72 patients, the mean volume of nodules or masses was measured as 9.37 ± 11.69 cm3 (mean ± standard deviation). The area and CT volume demonstrated a linear correlation of moderate strength (i.e., R = 0.58, RMSE: 9449.9 mm3 m3 in a linear regression analysis). The area and mean probability values exhibited a strong linear correlation (R = 0.73). The volume prediction performance based on a multivariable regression model was best with a mean probability and unit-adjusted area (i.e., RMSE: 7975.6 mm3, the smallest among the other variable parameters). Conclusions: The prediction model with the area and the mean probability based on the DLAD showed a rather accurate quantitative estimation of pulmonary nodule or mass volume and the change in serial CXRs.
Interstitial lung disease (ILD) is characterized by progressive pathological changes that require timely and accurate diagnosis. The early detection and progression assessment of ILD are important for effective management. This study introduces a novel quantitative evaluation method utilizing chest radiographs to analyze pixel-wise changes in ILD. Using a weakly supervised learning framework, the approach incorporates the contrastive unpaired translation model and a newly developed ILD extent scoring algorithm for more precise and objective quantification of disease changes than conventional visual assessments. The ILD extent score calculated through this method demonstrated a classification accuracy of 92.98% between ILD and normal classes. Additionally, using an ILD follow-up dataset for interval change analysis, this method assessed disease progression with an accuracy of 85.29%. These findings validate the reliability of the ILD extent score as a tool for ILD monitoring. The results of this study suggest that the proposed quantitative method may improve the monitoring and management of ILD.